🎉 M&A multiples are live!
Check it out!

Pluri Valuation Multiples

Discover revenue and EBITDA valuation multiples for Pluri and similar public comparables like Mesoblast, Cynata Therapeutics, and Aroa Biosurgery.

Pluri Overview

About Pluri

Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company’s technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.


Founded

2001

HQ

United States of America
Employees

118

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$35.2M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Pluri Financials

Pluri has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Pluri achieved revenue of $0.3M and an EBITDA of -$20.2M.

Pluri expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Pluri valuation multiples based on analyst estimates

Pluri P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $0.3M $0.3M XXX XXX XXX
Gross Profit n/a $0.3M XXX XXX XXX
Gross Margin NaN% 85% XXX XXX XXX
EBITDA -$27.7M -$20.2M XXX XXX XXX
EBITDA Margin -9645% -6204% XXX XXX XXX
Net Profit -$41.2M -$28.3M XXX XXX XXX
Net Margin -14370% -8687% XXX XXX XXX
Net Debt $11.9M $18.2M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Pluri Stock Performance

As of April 15, 2025, Pluri's stock price is $4.

Pluri has current market cap of $27.3M, and EV of $35.2M.

See Pluri trading valuation data

Pluri Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$35.2M $27.3M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Pluri Valuation Multiples

As of April 15, 2025, Pluri has market cap of $27.3M and EV of $35.2M.

Pluri's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Pluri's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Pluri and 10K+ public comps

Pluri Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $35.2M XXX XXX XXX
EV/Revenue 32.7x XXX XXX XXX
EV/EBITDA n/a XXX XXX XXX
P/E -1.2x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF n/a XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Pluri Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Pluri Valuation Multiples

Pluri's NTM/LTM revenue growth is Infinity%

Pluri's revenue per employee for the last fiscal year averaged $3K, while opex per employee averaged $0.2M for the same period.

Over next 12 months, Pluri's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Pluri's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Pluri and other 10K+ public comps

Pluri Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 14% XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth -27% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee $3K XXX XXX XXX XXX
Opex per Employee $0.2M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue 3078% XXX XXX XXX XXX
R&D Expenses to Revenue 3818% XXX XXX XXX XXX
Opex to Revenue 6896% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Pluri Public Comps

See public comps and valuation multiples for Regenerative Medicine and Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Lineage Cell Therapeutics XXX XXX XXX XXX XXX XXX
Arovella Therapeutics XXX XXX XXX XXX XXX XXX
Aroa Biosurgery XXX XXX XXX XXX XXX XXX
Cynata Therapeutics XXX XXX XXX XXX XXX XXX
Mesoblast XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Pluri M&A and Investment Activity

Pluri acquired  XXX companies to date.

Last acquisition by Pluri was  XXXXXXXX, XXXXX XXXXX XXXXXX . Pluri acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Pluri

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Pluri

When was Pluri founded? Pluri was founded in 2001.
Where is Pluri headquartered? Pluri is headquartered in United States of America.
How many employees does Pluri have? As of today, Pluri has 118 employees.
Who is the CEO of Pluri? Pluri's CEO is Mr. Yaky Yanay.
Is Pluri publicy listed? Yes, Pluri is a public company listed on NAS.
What is the stock symbol of Pluri? Pluri trades under PLUR ticker.
When did Pluri go public? Pluri went public in 1991.
Who are competitors of Pluri? Similar companies to Pluri include e.g. Lineage Cell Therapeutics, Arovella Therapeutics, Aroa Biosurgery, Cynata Therapeutics.
What is the current market cap of Pluri? Pluri's current market cap is $27.3M
What is the current revenue growth of Pluri? Pluri revenue growth between 2023 and 2024 was 14%.
Is Pluri profitable? Yes, Pluri is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.